Literature DB >> 8562667

Salivary cortisol responses and the risk for substance abuse in prepubertal boys.

H B Moss1, M M Vanyukov, C S Martin.   

Abstract

Investigations of adults with a psychoactive substance use disorder (PSUD) or antisocial behavior have reported diminished secretion of the adrenal "stress" hormone, cortisol. Consequently, we determined whether prepubertal sons of PSUD fathers, at high risk for later PSUD, differed from controls on salivary cortisol concentrations before, and after, an anticipated stressor. The roles of problematic behavioral disposition and state anxiety in the cortisol responses were also examined. A significant risk-group x time interaction for salivary cortisol concentrations was found, with high-risk boys secreting less salivary cortisol than controls when anticipating the task. High-risk boys also had significantly higher scores for aggressive delinquency and impulsivity that wholly accounted for the risk-group x time effect on salivary cortisol. Thus, cortisol hyporesponsivity was associated with the dysregulated behaviors prevalent among high-risk boys. The results suggest that cortisol hyporesponsivity could be a "marker" for later antisociality and PSUD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562667     DOI: 10.1016/0006-3223(94)00382-D

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  36 in total

1.  Biological sensitivity to context: the interactive effects of stress reactivity and family adversity on socioemotional behavior and school readiness.

Authors:  Jelena Obradović; Nicole R Bush; Juliet Stamperdahl; Nancy E Adler; W Thomas Boyce
Journal:  Child Dev       Date:  2010 Jan-Feb

Review 2.  Cortisol secretion patterns in addiction and addiction risk.

Authors:  William R Lovallo
Journal:  Int J Psychophysiol       Date:  2006-01-24       Impact factor: 2.997

Review 3.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

4.  Blunted hypothalamic-pituitary-adrenocortical axis responsivity to stress in persons with a family history of alcoholism.

Authors:  Kristen H Sorocco; William R Lovallo; Andrea S Vincent; Frank L Collins
Journal:  Int J Psychophysiol       Date:  2005-12-19       Impact factor: 2.997

5.  Allostasis model facilitates understanding race differences in the diurnal cortisol rhythm.

Authors:  Martie L Skinner; Elizabeth A Shirtcliff; Kevin P Haggerty; Christopher L Coe; Richard F Catalano
Journal:  Dev Psychopathol       Date:  2011-11

Review 6.  The limbic-hypothalamic-pituitary-adrenal axis and the development of alcohol use disorders in youth.

Authors:  Ty S Schepis; Uma Rao; Hardik Yadav; Bryon Adinoff
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

Review 7.  Biological mechanisms underlying the relationship between stress and smoking: state of the science and directions for future work.

Authors:  Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez
Journal:  Biol Psychol       Date:  2011-07-07       Impact factor: 3.251

Review 8.  Mechanisms of cortisol - Substance use development associations: Hypothesis generation through gene enrichment analysis.

Authors:  Kristine Marceau; Emily A Abel
Journal:  Neurosci Biobehav Rev       Date:  2018-05-23       Impact factor: 8.989

9.  Disentangling psychobiological mechanisms underlying internalizing and externalizing behaviors in youth: longitudinal and concurrent associations with cortisol.

Authors:  Paula L Ruttle; Elizabeth A Shirtcliff; Lisa A Serbin; Dahlia Ben-Dat Fisher; Dale M Stack; Alex E Schwartzman
Journal:  Horm Behav       Date:  2010-11-05       Impact factor: 3.587

10.  The 'antisocial' person: an insight in to biology, classification and current evidence on treatment.

Authors:  Chaturaka Rodrigo; Senaka Rajapakse; Gamini Jayananda
Journal:  Ann Gen Psychiatry       Date:  2010-07-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.